{
  "document": "Foundation_10",
  "Genomic Findings": [
    {
      "Name": "FBXW7 - Q41*",
      "Clinical": [],
      "No Clinical": ["Everolimus", "Temsirolimus"]
    },
    {
      "Name": "SSTK11 L85*",
      "Clinical": [],
      "No Clinical": ["Everolimus", "Temsirolimus"]
    },
    { "Name": "BRAF K601N", "Clinical": [], "No Clinical": [] },
    { "Name": "KRAS G12R", "Clinical": [], "No Clinical": [] },
    {
      "Name": "APC rearrangement exon 16",
      "Clinical": [],
      "No Clinical": []
    },
    {
      "Name": "ATRX S1125fs*28, ins*28, inversion exon 9",
      "Clinical": [],
      "No Clinical": []
    },

    {
      "Name": "CDKN2A/B p16INK4a Y44fs*1",
      "Clinical": [],
      "No Clinical": []
    },
    { "Name": "CREBBP R1446C", "Clinical": [], "No Clinical": [] },
    {
      "Name": "DNM T3A R882H, Y481*, P904L, splicing site 1015-1G>T, R635Q",
      "Clinical": [],
      "No Clinical": []
    },
    {
      "Name": "KEL splicing site 15993-1G>T",
      "Clinical": [],
      "No Clinical": []
    }
  ],
  "Biomakers findings": [
    {
      "Name": "Tumor Mutational Burden - 18 Muts/Mb",
      "Clinical": [
        "Atezolizumab",
        "Cemiplimab",
        "Durvalumab",
        "Nivolumab",
        "Pembrolizumab"
      ],
      "No Clinical": ["Avelumab"]
    },
    {
      "Name": "Microsatellite status - MSI-High Not Detected",
      "Clinical": [],
      "No Clinical": []
    },
    { "Name": "Tumor Fraction - 19%", "Clinical": [], "No Clinical": [] }
  ]
}
